| 1 |
35216372 | Novel Loss of Function Variant in BCKDK Causes a Treatable Developmental and Epileptic Encephalopathy. | 2022 Feb 18 |
2 |
| 2 |
34526485 | Inhibiting BCKDK in triple negative breast cancer suppresses protein translation, impairs mitochondrial function, and potentiates doxorubicin cytotoxicity. | 2021 Sep 15 |
3 |
| 3 |
32238881 | Phosphorylation of BCKDK of BCAA catabolism at Y246 by Src promotes metastasis of colorectal cancer. | 2020 May |
4 |
| 4 |
32529013 | Data on the proliferation and differentiation of C2C12 myoblast treated with branched-chain ketoacid dehydrogenase kinase inhibitor. | 2020 Aug |
4 |
| 5 |
32751134 | BDK Deficiency in Cerebral Cortex Neurons Causes Neurological Abnormalities and Affects Endurance Capacity. | 2020 Jul 29 |
3 |
| 6 |
30224059 | Ca2+-dependent inhibition of branched-chain α-ketoacid dehydrogenase kinase by thiamine pyrophosphate. | 2018 Oct 12 |
4 |
| 7 |
28501528 | BCKDK of BCAA Catabolism Cross-talking With the MAPK Pathway Promotes Tumorigenesis of Colorectal Cancer. | 2017 Jun |
2 |
| 8 |
26809120 | Mitochondrial response to the BCKDK-deficiency: Some clues to understand the positive dietary response in this form of autism. | 2016 Apr |
1 |
| 9 |
27054191 | Dataset reporting BCKDK interference in a BCAA-catabolism restricted environment. | 2016 Jun |
2 |
| 10 |
24449431 | Two novel mutations in the BCKDK (branched-chain keto-acid dehydrogenase kinase) gene are responsible for a neurobehavioral deficit in two pediatric unrelated patients. | 2014 Apr |
2 |